Dr. Martin Richman

Dr. Martin Richman
Dr. Richman is a Board-Certified Urologist practicing since 2005. He graduated from the Medical College of Ohio at the University of Toledo and completed his Surgical and Urology training at Case Western Reserve University and University Hospitals of Cleveland that included training at Cleveland V.A. Hospital, MetroHealth Medical center, and the Cleveland Clinic Foundation. He is a Diplomate of the American Board of Urology, Fellow of the American College of Surgeons (FACS) and is licensed by the State of Florida Board of Medicine. Dr. Richman has a special interest in Laser and minimally invasive treatment of prostate enlargement (BPH) including Robotic Aquablation of the prostate, Holmium laser enucleation of the prostate (HoLEP), Holmium laser vaporization of the prostate (HoLVP), Rezum steam ablation of the prostate and Urolift. He has been performing the HoLEP procedure since 2012 and was one of the first surgeons in the Southeast to offer this technology. He also has been performing High Intensity Focused Ultrasound (HIFU) for minimally invasive treatment of prostate cancer since 2008. He is a member of the American Urological Association, the Large Urology Group Practice Association, the Florida Urological Society, and the Florida Medical Association. He has numerous journal and textbook-chapter publications. Dr. Richman’s practice, Advanced Urology Institute, is one of the largest Urology group practices in the United States. He sees patients at offices in Safety Harbor and Trinity Florida and performs Aquablation at Mease Countryside Hospital in Safety Harbor Florida.
Medical School:

Medical College of Ohio at the University of Toledo

Residency:

Case Western Reserve University and University Hospitals of Cleveland

Undergraduate:

Indiana University

Locations

Advanced Urology Institute – Safety Harbor Office Safety Harbor, Florida

1840 Mease DrSafety Harbor, Florida, 34695United States
(727) 785-6011 |

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only